Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
Delayed Nasdaq  -  04:00 2022-11-30 pm EST
7.910 USD   +5.33%
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintains Buy Rating
MT
11/08PROTAGONIST THERAPEUTICS, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Days
:
Hours
:
Minutes
:
Seconds
Evolution of the average Target Price on PROTAGONIST THERAPEUTICS, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) PROTAGONIST THERAPEUTICS, INC.
Analyst Recommendations on PROTAGONIST THERAPEUTICS, INC.
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintains B..
MT
08/25JMP Securities Reinstates Protagonist Therapeutics at Market Outperform With $21 Price Tar..
MT
05/18Piper Sandler Adjusts Price Target on Protagonist Therapeutics to $35 From $60, Reiterates..
MT
05/05SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $30 from $50, Keeps Outperfo..
MT
02/11BTIG Initiates Protagonist Therapeutics at Buy With $55 Price Target
MT
2021JMP Securities Adjusts Price Target on Protagonist Therapeutics to $70 From $60, Keeps Mar..
MT
2021Protagonist Therapeutics : JMP Securities Adjusts Price Target on Protagonist Therapeutics..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 7,51 $
Average target price 33,50 $
Spread / Average Target 346%
High Price Target 41,00 $
Spread / Highest target 446%
Low Price Target 21,00 $
Spread / Lowest Target 180%
Consensus detail
Consensus revision (last 18 months)